MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$18,236K
EPS
-$0.31
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
13,562 12,092* 9,591 10,770
General and administrative
6,067 5,439* 5,169 5,816
Total operating expenses
19,629 17,530 14,760 16,586
Income (loss) from operations
-19,629 -17,530* -14,760 -16,586
Interest and investment income (expense)
1,847 1,688* 1,502 1,626
Other income (expense)
-730* -0
Other income (expense), net
1,847 2,418* 1,502 1,626
Net income (loss)
-17,782 -15,112* -13,258 -14,960
Net unrealized gain (loss) on marketable debt securities
-454 7 66 -12
Other comprehensive income (loss)
-454 7* 66 -12
Comprehensive income (loss)
-18,236 -15,105 -13,192 -14,972
Basic EPS
-0.31 -0.344 -0.31 -0.35
Diluted EPS
-0.31 -0.344 -0.31 -0.35
Basic Average Shares
57,538,833 43,965,428 42,272,104 42,270,855
Diluted Average Shares
57,538,833 43,965,428 42,272,104 42,270,855
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive income (loss)-$18,236K Interest and investmentincome (expense)$1,847K Net income (loss)-$17,782K Other comprehensiveincome (loss)-$454K Other income(expense), net$1,847K Income (loss) fromoperations-$19,629K Net unrealized gain(loss) on marketable...-$454K Total operatingexpenses$19,629K Research and development$13,562K General andadministrative$6,067K

Protara Therapeutics, Inc. (TARA)

Protara Therapeutics, Inc. (TARA)